Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

By Sawaki Akira   Yamao Kenji   Nakamura Tsuneya   Suzuki Takashi   Okubo Kenji   Hara Kazuo   Kawai Hiroki   Yamamura Yoshitaka   Ito Seiji   Mochiduki Yoshinari   Ohno Ryuzo  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a c-kit Mutation in Exon 11

By Kubota Keisuke   Katayama Atom   Takeshita Yutarou   Nozaki Koji   Ueda Tetsuya   Imamura Kazuhiro   Hiki Naoki   Nomura Sachiyo   Kaminishi Michio   Mafune Ken-Ichi  

Digestive Diseases and Sciences, Vol. 52, Iss. 7, 2007-07 ,pp. : 1725-1729

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Gastrointestinal Stromal Tumor with Imatinib Mesylate: A Retrospective Single-Center Experience in Heidelberg

By  

Digestive Diseases, Vol. 24, Iss. 1-2, 2006-05 ,pp. : 207-211

Karger

Access to resources Recommend Favorite

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

By Sicklick Jason   Lopez Nicole  

Journal of Gastrointestinal Surgery, Vol. 17, Iss. 11, 2013-11 ,pp. : 1997-2006

Springer Publishing Company

Access to resources Recommend Favorite